These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23435031)

  • 1. Dehydroepiandrosterone sulfate levels reflect endogenous luteinizing hormone production and response to human chorionic gonadotropin challenge in older female macaque (Macaca fascicularis).
    Moran FM; Chen J; Gee NA; Lohstroh PN; Lasley BL
    Menopause; 2013 Mar; 20(3):329-35. PubMed ID: 23435031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of subchronic infusion of dehydroepiandrosterone sulfate on serum gonadotropin levels and ovarian function in the cynomolgus monkey.
    Kowalski W; Chatterton RT
    Fertil Steril; 1992 Apr; 57(4):912-20. PubMed ID: 1532562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of higher-primate adrenal androgen secretion with estrogen-alone or estrogen-plus-progesterone intervention.
    Conley AJ; Stanczyk FZ; Morrison JH; Borowicz P; Benirschke K; Gee NA; Lasley BL
    Menopause; 2013 Mar; 20(3):322-8. PubMed ID: 23435030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction.
    Cedars MI; Steingold KA; de Ziegler D; Lapolt PS; Chang RJ; Judd HL
    Fertil Steril; 1992 Mar; 57(3):495-500. PubMed ID: 1531463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian and adrenal steroid production: regulatory role of LH/HCG.
    Piltonen T; Koivunen R; Morin-Papunen L; Ruokonen A; Huhtaniemi IT; Tapanainen JS
    Hum Reprod; 2002 Mar; 17(3):620-4. PubMed ID: 11870113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function.
    Zelinski-Wooten MB; Lanzendorf SE; Wolf DP; Chandrasekher YA; Stouffer RL
    J Clin Endocrinol Metab; 1991 Sep; 73(3):577-83. PubMed ID: 1908481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian adrenal interactions during the menopausal transition.
    Lasley BL; Crawford SL; McConnell DS
    Minerva Ginecol; 2013 Dec; 65(6):641-51. PubMed ID: 24346252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F; Hatala DA; Speroff L
    Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. II. Progesterone receptor expression in luteinizing granulosa cells.
    Chandrasekher YA; Brenner RM; Molskness TA; Yu Q; Stouffer RL
    J Clin Endocrinol Metab; 1991 Sep; 73(3):584-9. PubMed ID: 1908482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gonadotropin-releasing hormone agonist on human chorionic gonadotropin activity in granulosa cells of immature female rats.
    Tungmahasuk D; Fungbun N; Laoharatchatathanin T; Terashima R; Kurusu S; Kawaminami M
    J Reprod Dev; 2018 Apr; 64(2):129-134. PubMed ID: 29249775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional luteinizing hormone/chorionic gonadotropin receptors in human adrenal cortical H295R cells.
    Rao ChV; Zhou XL; Lei ZM
    Biol Reprod; 2004 Aug; 71(2):579-87. PubMed ID: 15084485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism.
    Castelo-Branco C; Martínez de Osaba MJ; Martínez S; Fortuny A
    Metabolism; 1996 Jan; 45(1):24-7. PubMed ID: 8544772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles.
    Zelinski-Wooten MB; Hutchison JS; Chandrasekher YA; Wolf DP; Stouffer RL
    J Clin Endocrinol Metab; 1992 Aug; 75(2):502-7. PubMed ID: 1639951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dibutyryl adenosine 3',5'-monophosphate, luteinizing hormone-releasing hormone, and aromatase inhibitor on simultaneous outputs of progesterone, 17 beta-estradiol, and human chorionic gonadotropin by term placental explants.
    Haning RV; Choi L; Kiggens AJ; Kuzma DL; Summerville JW
    J Clin Endocrinol Metab; 1982 Aug; 55(2):213-8. PubMed ID: 6282920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pituitary-gonadal axis in women with benign or malignant ovarian tumors.
    Blaakaer J; Djursing H; Hørding U; Bennett P; Toftager-Larsen K; Bock JE; Lebech PE
    Acta Endocrinol (Copenh); 1992 Aug; 127(2):127-30. PubMed ID: 1388313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.